Quantitative Biology > Populations and Evolution
[Submitted on 6 Nov 2020 (v1), last revised 11 Apr 2021 (this version, v5)]
Title:Phase transition in Kermack-McKendrick Model of Epidemic: Effects of Additional Nonlinearity and Introduction of Medicated Immunity
View PDFAbstract:Mathematical modelling of the spread of epidemics has been an interesting challenge in the field of epidemiology. The SIR Model proposed by Kermack and McKendrick in 1927 is a prototypical model of epidemiology. However, it has its limitations. In this paper, we show two independent ways of generalizing this model, the first one if the vaccine isn't discovered or ready to use and the next one, if the vaccine is discovered and ready to use. In the first part, we have pointed out a major over-simplification, i.e., assumption of variation of the time derivatives of the variables with the linear or quadratic powers of the individual variables and introduce two new parameters to incorporate further nonlinearity in the number of infected people in the model. As a result of this, we show how this additional nonlinearity, in the newly introduced parameters, can bring a significant shift in the peak time of infection, i.e., the time at which the infected population reaches maximum. We show that in special cases, even we can get a transition from epidemic to a non-epidemic stage of a particular infectious disease. We further study one such special case and treat it as a problem of phase transition. Then, we investigate all the necessary parameters of this phase transition, like the order parameter and critical exponent. We observe that $O_p \sim (q_c-q)^{\beta}$. {\it As far as we know the phase transition and its quantification in terms of the scaling behaviour is not yet know in the context of pandemic}. In the second part, we incorporate in the model, a consideration of artificial herd immunity and show how we can decrease the peak time of infection with a subsequent decrease in the maximum number of infected people.
Submission history
From: Muktish Acharyya [view email][v1] Fri, 6 Nov 2020 10:08:10 UTC (350 KB)
[v2] Wed, 18 Nov 2020 08:23:37 UTC (350 KB)
[v3] Fri, 18 Dec 2020 15:25:27 UTC (350 KB)
[v4] Wed, 17 Mar 2021 11:07:26 UTC (349 KB)
[v5] Sun, 11 Apr 2021 06:17:44 UTC (364 KB)
Current browse context:
q-bio.PE
Change to browse by:
References & Citations
Bibliographic and Citation Tools
Bibliographic Explorer (What is the Explorer?)
Connected Papers (What is Connected Papers?)
Litmaps (What is Litmaps?)
scite Smart Citations (What are Smart Citations?)
Code, Data and Media Associated with this Article
alphaXiv (What is alphaXiv?)
CatalyzeX Code Finder for Papers (What is CatalyzeX?)
DagsHub (What is DagsHub?)
Gotit.pub (What is GotitPub?)
Hugging Face (What is Huggingface?)
Papers with Code (What is Papers with Code?)
ScienceCast (What is ScienceCast?)
Demos
Recommenders and Search Tools
Influence Flower (What are Influence Flowers?)
CORE Recommender (What is CORE?)
arXivLabs: experimental projects with community collaborators
arXivLabs is a framework that allows collaborators to develop and share new arXiv features directly on our website.
Both individuals and organizations that work with arXivLabs have embraced and accepted our values of openness, community, excellence, and user data privacy. arXiv is committed to these values and only works with partners that adhere to them.
Have an idea for a project that will add value for arXiv's community? Learn more about arXivLabs.